BNP Paribas Financial Markets’s BridgeBio Pharma BBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$19M Buy
439,066
+124,364
+40% +$5.37M 0.01% 811
2025
Q1
$10.9M Buy
314,702
+289,492
+1,148% +$10M 0.01% 965
2024
Q4
$692K Sell
25,210
-12,829
-34% -$352K ﹤0.01% 2294
2024
Q3
$968K Buy
38,039
+24,738
+186% +$630K ﹤0.01% 1840
2024
Q2
$337K Sell
13,301
-124,643
-90% -$3.16M ﹤0.01% 2203
2024
Q1
$4.27M Buy
137,944
+10,684
+8% +$330K ﹤0.01% 1124
2023
Q4
$5.14M Sell
127,260
-21,632
-15% -$873K 0.01% 950
2023
Q3
$3.93M Buy
148,892
+41,840
+39% +$1.1M 0.01% 1028
2023
Q2
$1.84M Sell
107,052
-7,294
-6% -$125K ﹤0.01% 1314
2023
Q1
$1.9M Sell
114,346
-20,158
-15% -$334K ﹤0.01% 1369
2022
Q4
$1.02M Buy
+134,504
New +$1.02M ﹤0.01% 1562
2022
Q3
Sell
-129,984
Closed -$1.18M 4027
2022
Q2
$1.18M Sell
129,984
-116,964
-47% -$1.06M ﹤0.01% 1566
2022
Q1
$2.51M Buy
246,948
+220,646
+839% +$2.24M ﹤0.01% 1256
2021
Q4
$439K Buy
26,302
+3,320
+14% +$55.4K ﹤0.01% 2446
2021
Q3
$1.08M Buy
22,982
+16,641
+262% +$780K ﹤0.01% 1807
2021
Q2
$387K Sell
6,341
-8,141
-56% -$496K ﹤0.01% 2085
2021
Q1
$892K Buy
14,482
+3,303
+30% +$203K ﹤0.01% 1723
2020
Q4
$795K Sell
11,179
-5,956
-35% -$424K ﹤0.01% 1598
2020
Q3
$643K Buy
17,135
+8,458
+97% +$317K ﹤0.01% 1513
2020
Q2
$283K Sell
8,677
-17,037
-66% -$556K ﹤0.01% 1758
2020
Q1
$746K Buy
25,714
+22,467
+692% +$652K ﹤0.01% 1596
2019
Q4
$114K Sell
3,247
-51
-2% -$1.79K ﹤0.01% 2581
2019
Q3
$70.8K Buy
+3,298
New +$70.8K ﹤0.01% 2679